Showing results (101-110 of 110) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 16, 2017
[Dimebon delays the onset of symptoms of FUS-proteinopathy in transgenic mice]A V Maltsev, A V Deykin, R K Ovchinnikov, et al.Materials (Basel, Switzerland)|September 28, 2023
The Synthesis, Structure, and Luminescent Properties of TmMgB<sub>5</sub>O<sub>10</sub> CrystalsElena A Volkova, Victor V Maltsev, Alexander M Antipin, et al.Cell Calcium|August 10, 2018
Heterogeneity of calcium clock functions in dormant, dysrhythmically and rhythmically firing single pacemaker cells isolated from SA nodeMary S Kim, Alexander V Maltsev, Oliver Monfredi, et al.Doklady. Biochemistry and Biophysics|April 20, 2017
Detection of autoantibodies to potentially amyloidogenic protein, gamma-synuclein, in the serum of patients with amyotrophic lateral sclerosis and cerebral circulatory disordersA Yu Roman, E A Kovrazhkina, O D Razinskaya, et al.Journal of Medicinal Chemistry|January 19, 2019
Selective Targeting of Integrin αvβ8 by a Highly Active Cyclic PeptideFlorian Reichart, Oleg V Maltsev, Tobias G Kapp, et al.Science Signaling|June 14, 2018
A coupled-clock system drives the automaticity of human sinoatrial nodal pacemaker cellsKenta Tsutsui, Oliver J Monfredi, Syevda G Sirenko-Tagirova, et al.Neurobiology of Aging|August 10, 2015
C9ORF72 hexanucleotide repeat expansion in ALS patients from the Central European Russia populationNatalya Y Abramycheva, Elena V Lysogorskaia, Maria S Stepanova, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 17, 2024
[Targeting NMDAR/AMPAR: a promising pharmacotherapeutic approach for depressive disorders]D V Kurkin, E I Morkovin, D A Bakulin, et al.Bioorganic Chemistry|June 6, 2022
Synthesis of 2-chloropurine ribosides with chiral amino acid amides at C6 and their evaluation as A<sub>1</sub> adenosine receptor agonistsMaria Ya Berzina, Barbara Z Eletskaya, Alexei L Kayushin, et al.Frontiers in Immunology|April 10, 2025
Safety and immunogenicity of GamEvac-Combi, a heterologous rVSV- and rAd5-vectored Ebola vaccine: a randomized controlled multicenter clinical trial in the Republic of Guinea and RussiaDenis Y Logunov, Inna V Dolzhikova, Mamadou Y Boiro, et al.Pageof 11